Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for clinical studies.
Stata DX has raised $400K in total funding. The most recent round was Series A. The last funding was announced in February 2026.
Stata DX's investors include MassVentures.
Stata DX is headquartered in Cambridge, United States.
Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for clinical studies.
Stata DX is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stata DX — Funding & Investors." VCBacked, February 27, 2026, https://www.vcbacked.co/company/stata-dx. Accessed August 14, 2026.
VCBacked. (2026). Stata DX — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/stata-dx
{{cite web |title=Stata DX — Funding & Investors |url=https://www.vcbacked.co/company/stata-dx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated